Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Business Machines Corp (IBM) vs Nuvalent Inc (NUVL) Price & Performance

International Business Machines CorpTrade
Nuvalent IncTrade

Price performance (Past 24H)

Key statistics

International Business Machines Corp vs Nuvalent Inc — how do they compare? International Business Machines Corp trades at $210.84 (market cap $200.20B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: International Business Machines Corp is far larger — about 20.4× Nuvalent Inc's market cap, and International Business Machines Corp pays a 3.17% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.

IBMNUVL
Market Cap
$200.20B$9.81B
Volume
4,481,527
Sector
TechnologyTechnology
52-Week High
$329.23$123.96
52-Week Low
$211.20$72.16
Enterprise Value
$258.21B$8.52B
Dividend Yield
3.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

International Business Machines Corp

No Aura AI signal available yet.

Nuvalent Inc

Nuvalent (NUVL) trades at $123.96, unchanged on the day, with a bullish technical signal from moving averages but overbought oscillators. The company reported a net loss of $425.38 million for 2025 and negative cash flow from operations. Recent news is dominated by GSK's proposed acquisition of Nuvalent for $124 per share, announced in June 2026, which is under investigation by multiple law firms for fairness to shareholders.

The investment outlook is heavily influenced by the pending acquisition. While analyst consensus shows no sell ratings, the stock price is near the offer price, limiting upside. Key risks include the deal's completion and the company's ongoing losses. The primary opportunity is the acquisition premium, but fundamental challenges persist absent the deal.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM

About Nuvalent Inc

Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.

Read more on NUVL